Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07016945 · ClinicalTrials.gov registry record · NA
Reactions to Distress (RED) In Louisville, KY Study
A NA study of Threat Sensitivity, sponsored by University of Louisville.
- Recruiting
- Registry status
- NA
- Development phase
- 270
- Enrollment target
- 1
- Study location
NCT07016945: Recruiting NA study of Threat Sensitivity, sponsored by University of Louisville.
NCT07016945 is a NA study of Threat Sensitivity that is actively recruiting participants, run by University of Louisville. The registered enrollment target is 270 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07016945, a NA study of Threat Sensitivity, is actively recruiting participants, sponsored by University of Louisville.
- RECRUITING
- Registry status
- NA
- Development phase
- 270 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to understand whether race-related stress can impact the way people direct their attention and what interventions may be helpful for attention.
Primary Outcome
Free Viewing Task. This is the outcome measure for both manipulations listed above. To assess attention bias to threat, we will use a free-viewing task in which participants are instructed to freely view a pair of images side by side across two blocks of 60 trials each. In Block 1, participants will view two types of image pairs: one threatening (i.e., angry face) and one neutral (i.e., neutral facial expression) or both neutral.
Conditions Studied
Interventions
- BEHAVIORAL Stress and Mindfulness Intervention
Study Locations (1)
Kentucky
- Davidson Hall - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2024-07-25 |
| Est. Completion | 2027-04-30 |
| Phase | NA |
What NCT07016945 shows while recruiting
NCT07016945 is an interventional study that assigns participants to a tested intervention. The registered 270 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Threat Sensitivity appearing as the primary indexed condition, and to 1 intervention - of which Stress and Mindfulness Intervention is the first listed.
NCT07016945 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT07016945 about?
NCT07016945 is a clinical study titled "Reactions to Distress (RED) In Louisville, KY Study". The goal of this study is to understand whether race-related stress can impact the way people direct their attention and what interventions may be helpful for attention.
What is the current status of trial NCT07016945?
This trial is currently recruiting. It is a NA study. The enrollment target is 270 participants. The study started on 2024-07-25. Estimated completion is 2027-04-30.
What conditions does trial NCT07016945 study?
This clinical trial studies the following conditions: Threat Sensitivity.
What interventions are being tested in trial NCT07016945?
The interventions under investigation include: Stress and Mindfulness Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07016945?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07016945 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07016945's enrollment target sits among peer trials
270 387th of 2000 higher than 1,609 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00801489 · 270 participants · Phase 2
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- NCT04372485 · 270 participants · NA
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
- NCT04528446 · 270 participants
The Impact of Glomerular Disorders on Bone Quality and Strength
- NCT05215327 · 270 participants · Phase 2
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI